Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin in Post Diarrheal Haemolytic and Uremic Syndrome
NCT02336516Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2015
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in hemolytic uremic syndrome (HUS) comparing Azithromycin with Placebo (2 arms). Primary endpoint: Glomerular filtration rate at 1 month. Started Jul 2015; status: completed.
02
Drugs
azithromycin
03
Conditions
hemolytic uremic syndrome (HUS)
Beyond the preview
Go deeper on NCT02336516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02336516.